Prodrug based optimal drug delivery via membrane transporter/receptor (Q34452034)

2 August 2017

1 reference

title

Prodrug based optimal drug delivery via membrane transporter/receptor (English)

1 reference

2 August 2017

1 reference

Yang C

1

1 reference

2 August 2017

Tirucherai GS

series ordinal

2

1 reference

2 August 2017

Mitra AK

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

2

1 reference

2 August 2017

159-175

1 reference

Drug delivery via the mucous membranes of the oral cavity

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Prodrugs. Do they have advantages in clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Intestinal peptide transport systems and oral drug availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Carrier-mediated intestinal transport of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Expression cloning and cDNA sequencing of the Na+/glucose co-transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Hypoglycemic effect of intestinally administered monosaccharide-modified insulin derivatives in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Na(+)-dependent transport of aminopeptidase-resistant sugar-coupled tripeptides in rat intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Possible role of anion exchanger AE2 as the intestinal monocarboxylic acid/anion antiporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Role of the monocarboxylic acid transport system in the intestinal absorption of an orally active beta-lactam prodrug: carindacillin as a model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Bile acid transport systems as pharmaceutical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

The Absorption, Distribution and Excretion of 3H-Chlorambucil in Rats Bearing the Yoshida Ascites Sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Development of a statistical model for the formation of poly [acryloyl hydroxyethyl starch] microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Nucleoside transporters: molecular biology and implications for therapeutic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Functional and molecular characteristics of Na(+)-dependent nucleoside transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Role of organic cation transporters in drug absorption and elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Potocytosis: Sequestration and Transport of Small Molecules by Caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Vitamin B12 mediated oral delivery systems for granulocyte-colony stimulating factor and erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.2.159

21 January 2018

Identifiers

DOI

10.1517/14712598.1.2.159

1 reference

2 August 2017

1 reference